Acetamide

Acetamide

SCHEMBL4191263

CC(N)=O.CCC=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionaldehyde SCHEMBL7524407 0.90
Acetone SCHEMBL3205797 0.86
Propionaldehyde SCHEMBL16792801 0.84 ALDH1A1 (0.56)
Acetic Acid SCHEMBL10501034 0.83
Propionaldehyde SCHEMBL28298257 0.82
Butanone SCHEMBL11582162 0.80
Acetic Acid SCHEMBL28096565 0.80
Butanal SCHEMBL27351305 0.79
Propionaldehyde SCHEMBL14746311 0.79 ALDH1A1 (0.69)
Propionaldehyde SCHEMBL28312820 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3478278-B1 METHOD OF DETERMINING ACUTE OR NON-HEALING WOUNDS AGENCY SCIENCE TECH & RES (SG) 2024-06-12 EP disclosed
US-11234945-B2 Wound healing composition AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2022-02-01 US disclosed
US-20190262282-A1 A WOUND HEALING COMPOSITION AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2019-08-29 US disclosed
EP-3478278-A1 A WOUND HEALING COMPOSITION Agency for Science, Technology and Research (SG) 2019-05-08 EP disclosed
WO-2018004467-A1 A WOUND HEALING COMPOSITION AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-01-04 WO disclosed
EP-1357881-A4 INHIBITORS OF SPERMIDINE SYNTHASE FOR THE TREATMENT OF OSTEOARTHRITIS AND CARTILAGE REHABILITATION QUARK PHARMACEUTICALS INC (US) 2009-02-18 EP disclosed
US-20070280946-A1 Antibody to 5' -Deoxy-5' - Methylthioadenosine And Uses Thereof QUARK PHARMACUTICALS, INC. 2007-12-06 US disclosed
US-20040229886-A1 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation QUARK BIOTECH, INC. & SHIONOGI CO., LTD. 2004-11-18 US disclosed
US-6696454-B2 ADMINISTERING AN INHIBITOR OF SPERMIDINE BIOSYNTHESIS; PREFERRED ARE DCHA (DICYCLOHEXYLAMINE), ADODATO, AND TRANS-4-METHYLCYCLOHEXYLAMINE (4MCHA) QUARK BIOTECH, INC. 2004-02-24 US disclosed
EP-1357881-A2 INHIBITORS OF SPERMIDINE SYNTHASE FOR THE TREATMENT OF OSTEOARTHRITIS AND CARTILAGE REHABILITATION Quark Biotech, Inc. (US) 2003-11-05 EP disclosed
US-20020160978-A1 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation QUARK PHARMACEUTICALS, INC. 2002-10-31 US disclosed
WO-2002058623-A2 INHIBITORS OF SPERMIDINE SYNTHASE FOR THE TREATMENT OF OSTEOARTHRITIS AND CARTILAGE REHABILITATION QUARK BIOTECH, INC. (US) 2002-08-01 WO disclosed